All news

29 MAR 2021

Continued International Development

Spineway, specialized in the design of innovative surgical implants and instruments for the treatment of severe disorders of the spine, continues its international development with the organization of a workshop in Thailand on the use of its products, and the signature of a distribution agreement in the US state of Ohio.

Press releases
22 MAR 2021

Exclusive negotiations for the acquisition of a start-up in the field of spinal surgery

Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), announces that it has entered exclusive negotiations with a view to the acquisition of 100% of the capital of a European start-up specialized in the design, manufacture and sale of implants and instruments for spinal surgery.

Press releases
22 MAR 2021

Approval of the General Meeting’s resolutions Solid cash position to continue development

The Combined General Meeting of Spineway’s shareholders was held upon first notice of meeting on Monday, 8 March 2020, behind closed doors, at the Company’s registered office. The number of shares held by the shareholders represented amounted to 3 232 993 768 shares, i.e., a turnout of 25.79%.

Press releases
25 FEB 2021

Signature of a partnership with Tsunami Medical

Spineway announces the signature of a partnership with the Italian company Tsunami Medical, pioneer in innovative 3D-printed solutions, for the sale of Twin Peaks interbody cages produced with 3D printers.

Press releases
11 FEB 2021

Continued expansion in Asia

Spineway, specialized in the treatment of severe disorders of the spine, announces the first surgery in Thailand with Mont Blanc 3D+ instrumentation as well as the signature of an exclusive distribution agreement for the marketing of its products in Malaysia.

Press releases
28 JAN 2021

May 29 2020 Minutes of the Extraordinary and Ordinary General Shareholders’ Meeting of 26 May 2020 Capital decrease

The Extraordinary and Ordinary General Meeting of Spineway’s shareholders that was held behind closed doors on 26 May 2020, at 2 p.m. at the Group’s registered office located at 7 allée Moulin Berger, 69130 Ecully, adopted all the resolutions submitted by over 90% except for resolution no. 10, which was dismissed unanimously at the Board of Directors’ recommendation. During this Meeting, the decision was approved to decrease the company’s share capital by absorbing losses and decreasing the par value of the shares.

Press releases
28 JAN 2021

January 25 2021 2020 annual results

Spineway’s Board of Directors, at a meeting held on 25 January 2021 chaired by Stéphane Le Roux, closed the 2020 annual accounts.

Press releases
28 JAN 2021

January 29 2020 Appointment of Myriam Denis-Galland as Chief Financial Officer

Spineway, specialist in innovative spinal implants, announces the appointment of Myriam Denis as Chief Financial Officer. Her arrival allows Spineway to expand its Executive Committee and create a structure that will ensure the implementation of its development plan.

Press releases
28 JAN 2021

October 27 2020 – 2020 half-year results

Le Conseil d’Administration de Spineway, réuni le 26 Octobre 2020 sous la Présidence de Stéphane Le Roux, a arrêté les comptes semestriels 2020.

Press releases
LOADING